In this article in the September 27th issue of JAMA, the authors discuss the rationale and evidence for predicting fluid responsiveness in hemodynamically unstable patients. While this is a popular academic topic, its practical importance is not as clear. Some things, such as predicting performance on a SBT with a Yang-Tobin f/Vt, don't make much sense - just do the SBT if that's the result you're really interested in. The prediction of whether it will rain today is not very important if the difference in what I do is as small as tucking an umbrella into my bag or not. Neither the inconvenience of getting a little wet walking from the parking garage nor that of carrying the umbrella is very great. Similarly, a prediction of whether or not it will rain two months from now when I'm planning a trip to Cancun is not very valuable to me because the confidence intervals about the estimate are too wide to rely upon. Better to just stick with the base rates: how much rainfall is there in March in the Caribbean on an average year?
Our letter to the editor was not published in JAMA, so I will post it here:
Our letter to the editor was not published in JAMA, so I will post it here:
To the Editor: A couple of issues relating to the article about predicting responsiveness
to fluid bolus1 deserve attention. First, the authors made a mathematical error that may
cause confusion among readers attempting to duplicate the Bayesian calculations
described in article. The negative
predictive value (NPV) of a test is the proportion of patients with a negative
test who do not have the condition – the true negative rate.2
In each of the instances in which NPV is mentioned in the article, the
authors mistakenly report the proportion of patients with a negative test who do
have the condition. This value, 1-NPV,
is the false negative rate - the posterior probability of the condition in
those with a negative test.
Second, in the examples that discuss NPV, the authors use a prior
probability of fluid responsiveness of 50%.
A clinician who appropriately uses a threshold approach to decision
making3 must determine a probability
threshold above which treatment is warranted, considering the net utility of all possible outcomes
with and without treatment given that treatment’s risks and benefits4. Because
the risk of fluid administration in judicious quantities is low5, the threshold for fluid
administration is correspondingly low and fluid bolus may be warranted based on
prior probability alone, thus obviating additional testing. Even if additional testing is negative and
suggests a posterior probability of fluid responsiveness of only 10% (with an
upper 95% confidence limit of 18%), many clinicians would still judge a trial
of fluids to be justified because fluids are considered to be largely benign
and untreated hypovolemia is not4. (The upper confidence limit will be higher still if the prior probability was underestimated.) Finally, the posterior probabilities hinge critically on the estimates
of prior probabilities, which are notoriously nebulous and subjective. Clinicians are likely intuitively aware of
these quandaries, which may explain why empiric fluid bolus is favored over
passive leg raise testing outside of academic treatises6.
1. Bentzer
P, Griesdale DE, Boyd J, MacLean K, Sirounis D, Ayas NT. WIll this
hemodynamically unstable patient respond to a bolus of intravenous fluids? JAMA. 2016;316(12):1298-1309.
2. Fischer JE, Bachmann LM, Jaeschke R.
A readers' guide to the interpretation of diagnostic test properties: clinical
example of sepsis. Intensive Care Med. 2003;29(7):1043-1051.
3. Pauker SG, Kassirer JP. The
threshold approach to clinical decision making. N Engl J Med. 1980;302(20):1109-1117.
4. Tsalatsanis A, Hozo I, Kumar A,
Djulbegovic B. Dual Processing Model for Medical Decision-Making: An Extension
to Diagnostic Testing. PLoS One. 2015;10(8):e0134800.
5. Investigators TP. A Randomized Trial
of Protocol-Based Care for Early Septic Shock. N Engl J Med. 2014;370(18):1683-1693.
6. Marik PE, Monnet X, Teboul J-L.
Hemodynamic parameters to guide fluid therapy. Annals of Intensive Care. 2011;1:1-1.
Scott K Aberegg, MD, MPH
Andrew M Hersh, MD
The University of Utah School of Medicine
Salt Lake City, Utah
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.